A Global Life Sciences Outlook: Adapting in an Era of Transformation
It’s been argued that the future of pharma sales is in the global marketplace. As much of the industrialized world experiences a reduction in growth, pharma manufacturers are expanding their presence in emerging markets and adjacent developing nations. Pharma executives are announcing reduced reliance on “white pill/western market” sales, and focusing on acquiring or dedicating resources to lesser-served demographics. But success delivering pharmaceuticals to developed nations doesn’t necessarily translate to a global rollout. Join this panel of industry experts to explore different perspectives on the global life sciences landscape, discuss globalization trends impacting markets and organizations, and share considerations to grow revenue and market share.